m+Medelevator.RU
← Поиск публикаций
Scientific reports · 2025

Prognostic prediction in soft-tissue sarcomas using deep learning and digital pathology of tumor and margin areas.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Michot Audrey, Le Van-Linh, Coindre Jean-Michel, Velasco Valérie, Soussi Malika, Mesli Nouria, Italiano Antoine, Toulmonde Maud, Le Cesne Axel, Bonvalot Sylvie, Vanhersecke Lucile, Honoré Charles, Ngo Carine, Le Loarer François, Saut Olivier, Crombé Amandine

Аннотация

The histological FNCLCC grade is the primary prognostic factor in soft-tissue sarcoma (STS) but fails to fully capture high risk patients. This study aimed to develop and validate a deep learning (DL) model to predict metastatic relapse-free survival (MFS) using digital hematoxylin and eosin-stained whole-slide images. A retrospective analysis was conducted on 308 STS patients from two cancer centers, divided into a training cohort (149 patients) and two independent validation cohorts (64 and 95 patients). Supervised multi-instance learning convolutional neural network models were trained on distinct tumor regions-center (C), periphery (P), and margins (R)-to optimize predictive performance. Univariable analysis showed DL models using tumor center (DL-C), periphery (DL-P), and their combination (DL-CP) were consistently associated with MFS across cohorts, while models incorporating margins (DL-R and DL-CPR) demonstrated less reliable associations. Multivariable Cox regression confirmed that high risk scores from DL models were independent predictors of MFS. The DL-CP model outperformed FNCLCC grading in prognostic accuracy, with c-indices ≥ 0.74 in validation cohorts. Adding tumor margin information did not improve predictions.DL models focusing on tumor center and periphery provide superior prognostic value in STS, offering a streamlined, effective approach for digital pathology-based risk stratification.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты